RESUMO
The role of serotonin (5-HT) in the control of serum cortisol secretion was studied in 50 conscious beagle dogs. A significant rise in corticosteroids was observed after 1.5 and 3 mg/kg (P less than 0.01) iv fenfluramine, an indirect serotonergic agonist, as well as after 2 (P less than 0.05) and 3 mg/kg (P less than 0.01) iv quipazine, a direct agonist of 5-HT receptors. Both drugs exhibited a dose-related effect. A lower dose of fenfluramine, 0.5 mg/kg, was ineffective when administered iv, but raised serum cortisol (P less than 0.05) after direct injection into a lateral cerebral ventricle, through a chronically implanted brain cannula. The marked increases in corticosteroid concentration produced by the highest fenfluramine and quipazine doses were completely abolished by pretreatment with ketanserin, an antagonist of 5-HT2 receptors, which did not affect cortisol secretion when administered alone. These data suggest that brain serotonergic system plays a role in the control of cortisol secretion in conscious dogs.
Assuntos
Hidrocortisona/metabolismo , Serotonina/fisiologia , Animais , Cães , Fenfluramina/farmacologia , Hidrocortisona/sangue , Ketanserina , Piperidinas/farmacologia , Quipazina/farmacologia , Fatores de TempoRESUMO
In an earlier paper we described the synthesis and the antitrichomonas activity of 2-nitro-alpha,alpha,1-trimethyl-1H-imidazole-5-methanol (2). Starting from this compound, several derivatives have been synthesized. Among these, the phenyl carbonate 8 has been shown to possess activity equal to that of 2 and to be less toxic. This compound therefore is interesting in comparison with some antitrichomonas agents currently in use clinically. Before undertaking an in-depth investigation, compound 8 was subjected to some studies to see whether it has any effects on the central nervous system (CNS). Preliminary results show that, at therapeutic doses, it might induce unwanted CNS effects to a lesser degree than metronidazole.
Assuntos
Antitricômonas/síntese química , Nitroimidazóis/síntese química , Animais , Antitricômonas/farmacologia , Antitricômonas/uso terapêutico , Clostridium perfringens/efeitos dos fármacos , Interações Medicamentosas , Hexobarbital/farmacologia , Masculino , Camundongos , Testes de Sensibilidade Microbiana , Mycoplasma/efeitos dos fármacos , Nitroimidazóis/farmacologia , Nitroimidazóis/uso terapêutico , Pentilenotetrazol/antagonistas & inibidores , Sono/efeitos dos fármacos , Staphylococcus aureus/efeitos dos fármacos , Streptococcus pyogenes/efeitos dos fármacos , Estricnina/antagonistas & inibidores , Tricomoníase/tratamento farmacológico , Trichomonas vaginalis/efeitos dos fármacosRESUMO
Zetidoline (ZET), a rather selective dopamine (DA) D2-receptor blocker, was found to be equipotent to haloperidol and over 300 times as potent as sulpiride in activating the firing rate of substantia nigra dopaminergic neurons (SN-DA neurons) in unanesthetized rats. Moreover, like classic and atypical neuroleptics, ZET reversed and prevented apomorphine-induced inhibition of SN-DA neurons.
Assuntos
Antipsicóticos/farmacologia , Dopamina/fisiologia , Imidazóis/farmacologia , Neurônios/efeitos dos fármacos , Substância Negra/citologia , Animais , Apomorfina/farmacologia , Eletrofisiologia , Haloperidol/farmacologia , Masculino , Neurônios/fisiologia , Ratos , Ratos Endogâmicos , Substância Negra/efeitos dos fármacos , Sulpirida/farmacologiaAssuntos
Sistema Nervoso Central/efeitos dos fármacos , Oxazinas/síntese química , Oxazinas/farmacologia , Piridonas/farmacologia , Analgesia , Animais , Aspirina/farmacologia , Ataxia/induzido quimicamente , Barbitúricos/farmacologia , Clordiazepóxido/farmacologia , Clorpromazina/farmacologia , Comportamento Exploratório/efeitos dos fármacos , Masculino , Meprobamato/farmacologia , Camundongos , Morfina/farmacologia , Atividade Motora/efeitos dos fármacos , Músculos/efeitos dos fármacos , Oxazinas/toxicidade , Fenitoína/farmacologia , Ratos , Reflexo/efeitos dos fármacos , Convulsões/tratamento farmacológicoAssuntos
Amidas/síntese química , Compostos Heterocíclicos/síntese química , Oxazóis/síntese química , Tranquilizantes/síntese química , Amidas/farmacologia , Amidas/toxicidade , Animais , Aprendizagem da Esquiva/efeitos dos fármacos , Compostos Aza/síntese química , Compostos Aza/farmacologia , Compostos Aza/toxicidade , Comportamento Animal/efeitos dos fármacos , Sistema Nervoso Central/efeitos dos fármacos , Depressão Química , Compostos Heterocíclicos/farmacologia , Compostos Heterocíclicos/toxicidade , Dose Letal Mediana , Masculino , Camundongos , Atividade Motora/efeitos dos fármacos , Oxazóis/farmacologia , Oxazóis/toxicidade , Ratos , Tranquilizantes/farmacologia , Tranquilizantes/toxicidadeAssuntos
Antipsicóticos/farmacologia , Imidazóis/farmacologia , Receptores Dopaminérgicos/efeitos dos fármacos , Adenilil Ciclases/metabolismo , Animais , Comportamento Animal/efeitos dos fármacos , Ligação Competitiva/efeitos dos fármacos , AMP Cíclico/metabolismo , Técnicas In Vitro , Cinética , Masculino , Camundongos , Prolactina/sangue , Ratos , Ratos Endogâmicos , Espiperona/metabolismoRESUMO
The synthesis of two new series of 3,8-diazabicyclo [3.2.1] octane derivatives is described. The first series includes some 3-(or 8)-allyl and 3-(or 8)-(3,3-dimethylallyl) derivatives of 3,8-diazabicyclo [3.2.1] octane and 3,8-diazabicyclo [3.2.1] octane-2-one. The second series includes some esters and carbamates of 3-(3-hydroxy-3-methyl)butyl-3,8-diazabicyclo [3.2.1] octane. Two new 3,8-diazabicyclo [3.2.1] octane derivatives structurally related to propoxyphene are also described. Some pharmacological data of these compounds are reported.
Assuntos
Analgésicos/síntese química , Compostos Bicíclicos com Pontes/síntese química , Hidrocarbonetos Aromáticos com Pontes/síntese química , Piperazinas/síntese química , Animais , Comportamento Animal/efeitos dos fármacos , Compostos Bicíclicos com Pontes/farmacologia , Avaliação Pré-Clínica de Medicamentos , Atividade Motora/efeitos dos fármacos , Piperazinas/farmacologia , RatosRESUMO
As a part of a research on analgesic compounds 0-(4-methoxyphenyl)carbamoyl-3-aminopropiophenone oximes, 0-(4-methoxyphenyl)-carbamoyl-3-aminomethylcamphor oximes and 4-(4-methoxyphenyl)semicarbazones of 3-aminopropiophenones were prepared. The analgesic activity of these compounds was tested and the results of pharmacological screening are discussed.
Assuntos
Anti-Inflamatórios não Esteroides/síntese química , Cânfora/análogos & derivados , Propiofenonas/síntese química , Animais , Comportamento Animal/efeitos dos fármacos , Cânfora/síntese química , Cânfora/farmacologia , Sistema Nervoso Central/efeitos dos fármacos , Química Farmacêutica , Masculino , Camundongos , Camundongos Endogâmicos , Propiofenonas/farmacologia , Ratos , Ratos EndogâmicosRESUMO
The synthesis of the above-mentioned compounds, starting from the diethyl ester of 2,5-pyrrolidine dicarboxylic acid, is reported. The cis and trans isomers od the 2-phenylsubstituted acid were separated, and the trans form was resolved into the two chiral forms. Some amides were also prepared from these acids. The thio analogs (XIII) and (XVI) and the partially reduced derivatives (XIV) were synthesized. Some amides (VI) showed an interesting anti-anxiety effect in pharmacological models.
Assuntos
Ansiolíticos/síntese química , Imidazóis/síntese química , Animais , Comportamento Animal/efeitos dos fármacos , Ácidos Carboxílicos/síntese química , Ácidos Carboxílicos/farmacologia , Fenômenos Químicos , Química , Cães , Imidazóis/farmacologia , Camundongos , Pirróis/síntese química , Pirróis/farmacologiaRESUMO
The report describes the synthesis and pharmacology of some new derivatives of 1-(m or p-chlorophenyl)-2-imidazolidinone. These compounds were obtained either by reacting an amine with an N-(2-chloroethyl)-2-imidazolidinone or by reacting a 2-chloroethylamine with an N-substituted-2-imidazolidinone. Two compounds (II f, h) showed interesting psychotropic activity.
Assuntos
Imidazóis/síntese química , Psicotrópicos/síntese química , Animais , Comportamento Animal/efeitos dos fármacos , Fenômenos Químicos , Química , Feminino , Imidazóis/farmacologia , Imidazóis/toxicidade , Dose Letal Mediana , Masculino , Camundongos , Psicotrópicos/toxicidade , RatosRESUMO
Treatment of 4(5)-alkyl (or aryl)-2-aminoimidazoles with isoamyl nitrite in acetic acid gave rise to the corresponding 5(4)-substituted 2-amino-4(5)-hydroxyimino-4(5)H-imidazoles which were transformed into 3-acyl (or aroyl)-5-amino-1,2,4-oxadiazoles when treated in aqueous suspension. The results of a preliminary pharmacological investigation showed an interesting depressant activity on the CNS for one of these compounds, 5-amino-3-benzoyl-1,2,4-oxadiazole (III c). The pharmacological activities are correlated with the chemical substitutions on the oxadiazole ring.
Assuntos
Oxidiazóis/síntese química , Animais , Comportamento Animal/efeitos dos fármacos , Gatos , Sistema Nervoso Central/efeitos dos fármacos , Clordiazepóxido/farmacologia , Cães , Feminino , Haplorrinos , Masculino , Camundongos , Oxidiazóis/farmacologia , RatosRESUMO
3-(1-Methylethyl)-2-(4-methoxyphenyl)-3H-naphth[1,2-d] imidazole (MDL-035) has antiinflammatory activity in various antiinflammatory models such as carrageenin and nystatin oedemas, cotton pellet granuloma and adjuvant arthritis. The antiinflammatory potency of MDL-035 is greater than that of acetylsalicylic acid and phenylbutazone, but lower than that of indomethacin. MDL-035 has practically no gastroulcerogenic activity in rats, does not affect water or salt excretion, has no hormonal or antihormonal effects and has no other unwanted pharmacological effects. Its acute toxicity is very low.